Compounds > actinium
Page last updated: 2024-08-22

actinium and yttrium radioisotopes

actinium has been researched along with yttrium radioisotopes in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's1 (16.67)24.3611
2020's4 (66.67)2.80

Authors

AuthorsStudies
Apostolidis, C; Esaias, C; Hobbs, RF; Huso, DL; Morgenstern, A; Sgouros, G; Song, H; Vajravelu, R1
Bednarz, B; Lee, D; Li, M; Schultz, MK1
Albisinni, S; Aoun, F; Mjaess, G; Roumeguère, T1
Baum, RP; Kulkarni, HR; Zhang, J1
Harada, Y; Higashi, T; Katagiri, T; Nagayama, S; Nakamura, Y; Sudo, H; Sugyo, A; Tsuji, AB1
Bander, NH; Ho, B; Molina, A; Nanus, DM; Nauseef, JT; Osborne, JR; Stangl-Kremser, J; Sternberg, CN; Sun, M; Tagawa, S; Thomas, J1

Reviews

1 review(s) available for actinium and yttrium radioisotopes

ArticleYear
Antibodies targeting Prostate-Specific Membrane Antigen positive prostate cancer: from diagnostic imaging to theranostics.
    Current opinion in oncology, 2021, 09-01, Volume: 33, Issue:5

    Topics: Actinium; Humans; Male; Positron Emission Tomography Computed Tomography; Precision Medicine; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Yttrium Radioisotopes

2021

Other Studies

5 other study(ies) available for actinium and yttrium radioisotopes

ArticleYear
Radioimmunotherapy of breast cancer metastases with alpha-particle emitter 225Ac: comparing efficacy with 213Bi and 90Y.
    Cancer research, 2009, Dec-01, Volume: 69, Issue:23

    Topics: Actinium; Alpha Particles; Animals; Antibodies, Monoclonal; Bismuth; Female; Immunotoxins; Isotope Labeling; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Transgenic; Radioimmunotherapy; Radioisotopes; Rats; Receptor, ErbB-2; Tissue Distribution; Yttrium Radioisotopes

2009
Modeling Cell and Tumor-Metastasis Dosimetry with the Particle and Heavy Ion Transport Code System (PHITS) Software for Targeted Alpha-Particle Radionuclide Therapy.
    Radiation research, 2018, Volume: 190, Issue:3

    Topics: Actinium; Alpha Particles; Beta Particles; Bismuth; Dose-Response Relationship, Radiation; Humans; Lead Radioisotopes; Lutetium; Neoplasm Metastasis; Neoplasms; Radioisotopes; Yttrium Radioisotopes

2018
225Ac-DOTATOC-Targeted Somatostatin Receptor α-Therapy in a Patient With Metastatic Neuroendocrine Tumor of the Thymus, Refractory to β-Radiation.
    Clinical nuclear medicine, 2021, Dec-01, Volume: 46, Issue:12

    Topics: Actinium; Humans; Neuroendocrine Tumors; Octreotide; Receptors, Somatostatin; Yttrium Radioisotopes

2021
FZD10-targeted α-radioimmunotherapy with
    Cancer science, 2022, Volume: 113, Issue:2

    Topics: Actinium; Alpha Particles; Animals; Antibodies, Monoclonal, Humanized; Cell Line, Tumor; Frizzled Receptors; Humans; Mice; Radioimmunotherapy; Radiotherapy Dosage; Remission Induction; Sarcoma, Synovial; Tissue Distribution; Tumor Burden; Xenograft Model Antitumor Assays; Yttrium Radioisotopes

2022
Prognostic value of neutrophil-to-lymphocyte ratio in patients with metastatic castration-resistant prostate cancer receiving prostate-specific membrane antigen targeted radionuclide therapy.
    The Prostate, 2023, Volume: 83, Issue:14

    Topics: Actinium; Humans; Lymphocytes; Male; Neutrophils; Prognosis; Prospective Studies; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes

2023